Orivam News from the source.

GlaxoSmithKline Pharmaceuticals Limited

NSE GLAXO BSE 500660 INE159A01016

0 filings · 0 analysed

2,710.00 +9.42% over 1 year
2,250 2,500 2,750 3,000 Nov 25 Jan 26 Apr 26 Jun 26 Aug 26 Nov 26

  1. HEALTHCARE MOFSL PR PG024

    Investment Guru India Neutral +0.00% in 1h

    The report forecasts GSK Pharma sales growth of 15.1% YoY and PAT growth of 22.2% YoY in 2QFY27.

  2. qsif Factsheet October 2026

    QSIF Factsheet +0.00% in 1h

    The factsheet discloses GlaxoSmithKline Pharmaceuticals as an unhedged holding at 3.94% of NAV.

Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.

What the desks said

03 Oct 2026, 15:02 IST Motilal Oswal (MOFSL) via Investment Guru India Neutral

The report forecasts GSK Pharma sales growth of 15.1% YoY and PAT growth of 22.2% YoY in 2QFY27.

Read this note →
04 Sep 2026, 19:46 IST quant Mutual Fund (qsif) via QSIF

The factsheet discloses GlaxoSmithKline Pharmaceuticals as an unhedged holding at 3.94% of NAV.

Read this note →

Announcement timeline

No filings stored for this company yet.

Never miss the next one.

Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.

Get the daily brief